Results 201 to 210 of about 987,468 (263)

Benralizumab in Corticosteroid-Refractory Drug Reaction With Eosinophilia and Systemic Symptoms: A Case Report. [PDF]

Cureus
Ross KR, Horesh E, Fang MM, Keller JJ.
europepmc   +1 more source

The Pattern of Adverse Drug Reaction Reporting at a Regional Pharmacovigilance Center in North India: A Retrospective Observational Study. [PDF]

Cureus
Gupta PK, Kaur J, Devi G, Chaudhary S, Maria J.   +4 more
europepmc   +1 more source

Hospital Pharmacists' Perspectives on Adverse Drug Reaction Reporting in Developed and Developing Countries: A Comparative Pilot Study. [PDF]

Pharmacy (Basel)
Khalid J, Temedie-Asogwa T, Zakeri M, Sansgiry SS.   +3 more
europepmc   +1 more source

Facilitating Expedited Drug Approval– the Past, Present, and Future of Clinical Trials for Pediatric Rheumatic Disease

Arthritis Care &Research, Accepted Article.
Pamela F. Weiss, Hermine I. Brunner
wiley   +1 more source

DeepADR: multimodal prediction of adverse drug reaction frequency by integrating early-stage drug discovery information via Kolmogorov-Arnold networks. [PDF]

Brief Bioinform
Wan J, Jia C, Dong D, Chen Y, Lin YC, He Y, Huang HY, Huang HD.   +7 more
europepmc   +1 more source

Adverse drug reaction reporting with the Med Safety app in Uganda: a cluster-randomised, controlled trial.

Lancet Glob Health
Kiguba R, Ndagije HB, Mwebaza N, Ssenyonga R, Giibwa L, Isabirye G, Owiny J, Nambasa V, Ntale I, Atuhaire J, Mwesigwa D, Mayengo J, Walusimbi D, Mugisa I, Katureebe C, Harrison K, Karamagi C, Pirmohamed M.   +17 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Neutrophilic drug reactions

Clinics in Dermatology, 2020
Neutrophilic drug reactions are unique eruptions that can affect hospitalized patients and share a common pathophysiology with neutrophils as the key mediators of inflammation. They range in clinical presentation from papules and plaques to bullae and erosions to pustules. Although there is some overlap in presentation, each has distinguishing features
Alexandra J, Coromilas, Stephanie M, Gallitano   +1 more
openaire   +2 more sources

Drug Hypersensitivity Reactions

Medical Clinics of North America, 2020
Drug hypersensitivity reactions (DHRs) may be classified based on timing (immediate vs delayed), mechanisms, and pattern of clinical manifestations. Management may include selection of alternative, non-cross reactive agents, drug allergy testing, graded challenge and/or desensitization.
Mark S, Dykewicz, Jason K, Lam
openaire   +2 more sources